Monopar Therapeutics Inc. (MNPR) Financials
MNPR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 8.6 million | 2.0 million |
| 2023-06-30 | 10.3 million | 2.5 million |
| 2023-03-31 | 11.8 million | 2.9 million |
| 2022-12-31 | 13.2 million | 3.1 million |
MNPR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.9 million | 474138 |
| 2023-06-30 | -2.1 million | 473296 |
| 2023-03-31 | -2.3 million | 476209 |
| 2022-12-31 | -1.3 million | 393417 |
MNPR Net Income
No data available :(
MNPR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 8.5 million | - | - |
| 2023-06-30 | 10.2 million | - | - |
| 2023-03-31 | 11.7 million | - | - |
| 2022-12-31 | 13.1 million | - | 8408 |
MNPR Shares Outstanding
MNPR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.3 million | 749474 | - |
| 2023-06-30 | - | 1.6 million | 733496 | - |
| 2023-03-31 | - | 1.7 million | 871675 | - |
| 2022-12-31 | - | 2.1 million | 806030 | - |
MNPR Cost of Revenue
No data available :(
MNPR
Price: $0.65
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123422
Market Capitalization: 8.9 million